Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Sepracor's STEDESA™ (Eslicarbazepine Acetate) New Drug Application Formally Accepted For Review By The FDA
Sepracor Inc. (Nasdaq: SEPR) today announced that it has been notified by the U.S. Food and Drug Administration (FDA) that the New Drug Application (NDA) for STEDESA™ (eslicarbazepine acetate) has been accepted for filing and is now under formal review. As previously announced, the NDA for STEDESA was submitted to the FDA on March 31, 2009 for adjunctive therapy in the treatment of partial-onset seizures in adults with epilepsy. The acceptance of the filing means that the FDA has made a threshold determination that the NDA is sufficiently complete to permit a substantive review.

46 R&D 100 Awards For 2009 Won By DOE-Funded Research Projects
U.S. Secretary of Energy Steven Chu has announced that Energy Department-funded researchers have won 46 of the 100 awards given out this year by R&D Magazine for the most outstanding technology developments with promising commercial potential. The coveted awards are presented annually in recognition of exceptional new products, processes, materials or software developed throughout the world and introduced into the market the previous year.
News of the day
Mayo Clinic Cancer Center Support Grant Renewed By NCI, Comprehensive Status Extended
The Mayo Clinic Cancer Center (MCCC) received an additional five years of National Cancer Institute (NCI) funding and re-designation as a comprehensive cancer center, according to Robert Diasio, M.D., the center"s director. Mayo Clinic has the only NCI-designated comprehensive cancer center conducting research at three distinct locations across the United States.
Mental Health

New York Agency Loses Grant To Expand Services For Families Affected By HIV/AIDS

AIDS Community Services of Western New York (ACS), a Buffalo-based agency that provides medical treatment and social services for individuals and families affected by HIV/AIDS, has lost a $288,500 grant from the Junior League of Buffalo that was to be used to expand a primary care center, the Charlotte Business Journal reports. The Junior League of Buffalo cited a contract agreement that said construction was to be completed by Dec. 31, 2008 as the reason for the decision; construction has yet to begin. ACS President Ronald Silverio said the agency will move forward with its expansion plans, although they will be further delayed, and anticipates that they will receive other funding to replace the loss. Since the ACS began planning this project, they have also experienced cuts in state funding, according to the Journal (Drury, Charlotte Business Journal, 6/19). This information was reprinted from dailyreports.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily U.S. HIV/AIDS Report, search the archives and sign up for email delivery at dailyreports.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009